Cover ImageSALE
市場調查報告書

神經功能替代 (人工神經)的全球全球市場:2017∼2021年

Global Neuroprosthetics Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 341179
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
神經功能替代 (人工神經)的全球全球市場:2017∼2021年 Global Neuroprosthetics Market 2017-2021
出版日期: 2017年09月22日 內容資訊: 英文 79 Pages
簡介

神經功能替代 (人工神經) 是融合神經科學和生物醫學工程設計的嵌入型設備。改善患病的神經系統功能給予電刺激。全球人工神經市場預計2017∼2021年以7.08%的年複合成長率擴大。

本報告提供全球神經功能替代 (人工神經) 市場現狀及2017∼2021年的成長預測的相關調查,市場規模,各用途,各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各用途市場區分

  • 市場概要
  • 神經調整設備市場
  • 認識設備市場

第7章 各終端用戶市場區隔

  • 市場概要
  • 醫院
  • 外科手術中心(ASC)

第8章 各地區市場市場區隔

  • 市場方案
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 決策結構

第10章 推動市場的要素與課題

第11章 市場趨勢

第12章 供應商環境

  • 競爭模式
  • 其他值得注意的供應商

第13章 主要供應商分析

  • Abbott (St. Jude Medical)
  • Boston Scientific
  • Cochlear
  • Medtronic
  • Sonova

第14章 附錄

  • 簡稱一覽

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR15179

About Neuroprosthetics

The neural prosthetics systems rely on the detection and processing of brain activity involved in the planning and execution of movement intentions. Neuroprosthetics are used for individuals suffering an amputation as it restores the damaged motor, sensory, and autonomic functions by stimulating various parts of the nervous system such as nerves, muscles, spinal cord, and brain. Neurological scientists are developing neural interfaces to record and control signals directly from the nervous system. They are also developing a brain-spinal interface to restore voluntary gait control after a spinal cord injury (SCI).

Technavio's analysts forecast the global neuroprosthetics market to grow at a CAGR of 7.08% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global neuroprosthetics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Neuroprosthetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott (St. Jude Medical)
  • Boston Scientific
  • Cochlear
  • Medtronic
  • Sonova

Other Prominent Vendors

  • Atrotech
  • Autonomic Technologies
  • BrainGate
  • Cyberonics
  • DJO Global
  • electroCore
  • Mainstay Medical
  • Nevro
  • NeuroMetrix
  • NeuroPace
  • SensArs
  • Soterix Medical
  • Cogentix Medical
  • Zynex Medical

Market driver

  • Rising prevalence of SCIs
  • For a full, detailed list, view our report

Market challenge

  • High cost of neuroprosthetics products
  • For a full, detailed list, view our report

Market trend

  • Increasing focus on research
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • Neuromodulation devices
  • Cognitive devices

PART 07: Market segmentation by end-users

  • Market overview
  • Hospitals
  • ASCs

PART 08: Geographical segmentation

  • Market scenario
  • Neuroprosthetics market in Americas
  • Neuroprosthetics market in EMEA
  • Neuroprosthetics market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Increasing focus research
  • Technological advancements

PART 12: Vendor landscape

  • Vendor landscape
  • Other prominent vendors

PART 13: Key vendor analysis

  • Abbott (St. Jude Medical)
  • Boston Scientific
  • Cochlear
  • Medtronic
  • Sonova

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global neuroprosthetics market 2016-2021 ($ billions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global neuroprosthetics market by application 2016
  • Exhibit 04: Global neuroprosthetics market by neuromodulation devices 2016-2021 ($ billions)
  • Exhibit 05: Global neuroprosthetics market by cognitive devices 2016-2021 ($ billions)
  • Exhibit 06: Global neuroprosthetics market by geography 2016 (%)
  • Exhibit 07: Global neuroprosthetics market by geography 2021 (%)
  • Exhibit 08: Overview: Neuroprosthetics market in US
  • Exhibit 09: Neuroprosthetics market in Americas 2016-2021 ($ billions)
  • Exhibit 10: Overview: Neuroprosthetics market in Germany
  • Exhibit 11: Neuroprosthetics market in EMEA 2016-2021 ($ billions)
  • Exhibit 12: Overview: Neuroprosthetics market in Japan
  • Exhibit 13: Neuroprosthetics market in APAC 2016-2021 ($ billions)
  • Exhibit 14: Competitive structure analysis of global neuroprosthetics market 2016
  • Exhibit 15: Abbott: Key highlights
  • Exhibit 16: Abbott: Strength assessment
  • Exhibit 17: Abbott: Strategy assessment
  • Exhibit 18: Abbott: Opportunity assessment
  • Exhibit 19: Boston Scientific: Key highlights
  • Exhibit 20: Boston Scientific: Strength assessment
  • Exhibit 21: Boston Scientific: Strategy assessment
  • Exhibit 22: Boston Scientific: Opportunity assessment
  • Exhibit 23: Cochlear: Key highlights
  • Exhibit 24: Cochlear: Strength assessment
  • Exhibit 25: Cochlear: Strategy assessment
  • Exhibit 26: Cochlear: Opportunity assessment
  • Exhibit 27: Medtronic: Key highlights
  • Exhibit 28: Medtronic: Strength assessment
  • Exhibit 29: Medtronic: Strategy assessment
  • Exhibit 30: Medtronic: Opportunity assessment
  • Exhibit 31: Sonova: Key highlights
  • Exhibit 32: Sonova: Strength assessment
  • Exhibit 33: Sonova: Strategy assessment
  • Exhibit 34: Sonova: Opportunity assessment
Back to Top